Skip to contentC
Cannabis Suisse Corp.
C
CSUICannabis Suisse Corp. Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$0.00$0.00derived— vs Q4 2021 Net Income$57.79K$57.79KderivedN/M vs Q4 2021 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cannabis Suisse Corp. · CIK 1680132 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$22,766N/M Operating Cash Flowderived$645N/M ended May 31, 2022 · filed Nov 23, 2022 · 176 d after period end